Advances in Hematological Malignancies
Recent years have witnessed remarkable advancements in the domain of hematological malignancies. Novel approaches such as targeted agents, immunotherapies, and gene editing are transforming the outlook for patients with blood cancers. Clinical trials continue to explore these innovative techniques, offering promise for more curative treatment optio